Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
“Pharmaceutical Traceability Market” research report 2022-2030 provides a meticulous assessment of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and…
By Pharmatrax Author
No Comments
The biotechnology and pharmaceutical sectors have showcased resilience and grit in the face of the pandemic, continuously evolving and innovating for better outcomes. The industry…
By Pharmatrax Author
Category: News
No Comments
The fate of some marquee brands is uncertain as the government phases out codeine-based cough formulations and a handful of fixed-dose combination (FDC) drugs. Some of these…
By Pharmatrax Author
Category: News
No Comments
On 28 October 2021, the Parliament of the European Union (EU) adopted the revised Network and Information Security (NIS) Directive, commonly referred to as NIS-2,…
By Pharmatrax Author
Category: News
No Comments
According to research, post-pandemic R&D growth is healthy in the pharma industry with the number of drugs in the R&D pipeline now exceeding 20,000 in…
By Pharmatrax Author
No Comments
“Pharmaceutical Traceability Market” research report 2022-2030 provides a meticulous assessment of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and…
By Pharmatrax Author
No Comments
The biotechnology and pharmaceutical sectors have showcased resilience and grit in the face of the pandemic, continuously evolving and innovating for better outcomes. The industry…
By Pharmatrax Author
Category: News, Press Release
No Comments
The fate of some marquee brands is uncertain as the government phases out codeine-based cough formulations and a handful of fixed-dose combination (FDC) drugs. Some of…
By Pharmatrax Author
Category: Technoloy
No Comments
On 28 October 2021, the Parliament of the European Union (EU) adopted the revised Network and Information Security (NIS) Directive, commonly referred to as NIS-2,…
By Pharmatrax Author
Category: News, Press Release
No Comments
External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success. IPOPBA – STOCK.ADOBE.COM According to…